Comparison of speedy PCR-SSP method and serological typing of HLA-A24 for JAPANESE cancer patients

Journal of Immunoassay and Immunochemistry

Volumn 32, Issue 2, 2011, Pages 93-102

  Nakatsugawa, Munehide ^a   Hirohashi, Yoshihiko ^a   Torigoe, Toshihiko ^a   Inoda, Satoko ^a   Kiriyama, Kenji ^a   Tamura, Yasuaki ^a   Sato, Eiji ^a   Takahashi, Hiroki ^a   Sato, Noriyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

HLA A24; HLA typing; monoclonal antibody; PCR SSP

Indexed keywords

GENOMIC DNA; HLA A24 ANTIGEN;

ACCURACY; ANTIGEN DETECTION; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; JAPANESE; MALE; METHODOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE SPECIFIC PRIMER METHOD; SEROLOGY; TEMPERATURE;

ANTIBODIES, MONOCLONAL; BASE SEQUENCE; DNA PRIMERS; FEMALE; FLOW CYTOMETRY; HLA-A ANTIGENS; HUMANS; JAPAN; MALE; NEOPLASMS; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 79952588641     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321819.2010.543219     Document Type: Article

References (21)

1. Hirohashi, Y.; Torigoe, T.; Maeda, A.; Nabeta, Y.; Kamiguchi, K.; Sato, T.; Yoda, J.; Ikeda, H.; Hirata, K.; Yamanaka, N.; Sato, N. An HLA-A24-Restricted Cytotoxic T Lymphocyte Epitope of a Tumor- Associated Protein, Survivin. Clin. Cancer Res. 2002, 8, 1731-1739. (Pubitemid 34633728)
2. Sato, Y.; Nabeta, Y.; Tsukahara, T.; Hirohashi, Y.; Syunsui, R.; Maeda, A.; Sahara, H.; Ikeda, H.; Torigoe, T.; Ichimiya, S.; Wada, T.; Yamashita, T.; Hiraga, H.; Kawai, A.; Ishii, T.; Araki, N.; Myoui, A.; Matsumoto, S.; Umeda, T.; Ishii, S.; Kawaguchi, S.; Sato, N. Detection and Induction of CTLs Specific for SYT-SSX-Derived Peptides in HLA-A24(θ) Patients With Synovial Sarcoma. J. Immunol. 2002, 169, 1611-1618. (Pubitemid 34809210)
3. Ida, K.; Kawaguchi, S.; Sato, Y.; Tsukahara, T.; Nabeta, Y.; Sahara, H.; Ikeda, H.; Torigoe, T.; Ichimiya, S.; Kamiguchi, K.; Wada, T.; Nagoya, S.; Hiraga, H.; Kawai, A.; Ishii, T.; Araki, N.; Myoui, A.; Matsumoto, S.; Ozaki, T.; Yoshikawa, H.; Yamashita, T.; Sato, N. Crisscross CTL Induction by SYT-SSX Junction Peptide and Its HLA-A-2402 Anchor Substitute. J. Immunol. 2004, 173, 1436-1443. (Pubitemid 38924325)
4. Idenoue, S.; Hirohashi, Y.; Torigoe, T.; Sato, Y.; Tamura, Y.; Hariu, H.; Yamamoto, M.; Kurotaki, T.; Tsuruma, T.; Asanuma, H.; Kanaseki, T.; Ikeda, H.; Kashiwagi, K.; Okazaki, M.; Sasaki, K.; Sato, T.; Ohmura, T.; Hata, F.; Yamaguchi, K.; Hirata, K.; Sato, N. A Potent Immunogenic General Cancer Vaccine That Targets Survivin, An Inhibitor of Apoptosis Proteins. Clin. Cancer Res. 2005, 11, 1474-1482. (Pubitemid 40315229)
5. Hariu, H.; Hirohashi, Y.; Torigoe, T.; Asanuma, H.; Hariu, M.; Tamura, Y.; Aketa, K.; Nabeta, C.; Nakanishi, K.; Kamiguchi, K.; Mano, Y.; Kitamura, H.; Kobayashi, J.; Tsukahara, T.; Shijubo, N.; Sato, N. Aberrant Expression and Potency as a Cancer Immunotherapy Target of Inhibitor of Apoptosis Protein Family, Livin/ML-IAP In Lung Cancer. Clin. Cancer Res. 2005, 11, 1000-1009. (Pubitemid 40175747)
6. Tsukahara, T.; Kawaguchi, S.; Torigoe, T.; Kimura, S.; Murase, M.; Ichimiya, S.; Wada, T.; Kaya, M.; Nagoya, S.; Ishii, T.; Tatezaki, S.; Yamashita, T.; Sato, N. Prognostic Impact and Immunogenicity of a Novel Osteosarcoma Antigen, Papillomavirus Binding Factor, In Patients With Osteosarcoma. Cancer Sci. 2008, 99, 368-375. (Pubitemid 351228494)
7. Sato, E.; Torigoe, T.; Hirohashi, Y.; Kitamura, H.; Tanaka, T.; Honma, I.; Asanuma, H.; Harada, K.; Takasu, H.; Masumori, N.; Ito, N.; Hasegawa, T.; Tsukamoto, T.; Sato, N. Identification of An Immunogenic CTL Epitope of HIFPH3 For Immunotherapy of Renal Cell Carcinoma. Clin. Cancer Res. 2008, 14, 6916-6923.
8. Inoda, S.; Hirohashi, Y.; Torigoe, T.; Nakatsugawa, M.; Kiriyama, K.; Nakazawa, E.; Harada, K.; Takasu, H.; Tamura, Y.; Kamiguchi, K.; Asanuma, H.; Tsuruma, T.; Terui, T.; Ishitani, K.; Ohmura, T.; Wang, Q.; Greene, M. I.; Hasegawa, T.; Hirata, K.; Sato, N. Cep55/c10orf3, a Tumor Antigen Derived From a Centrosome Residing Protein In Breast Carcinoma. J. Immunother. 2009, 32, 474-485.
9. Tsuruma, T.; Hata, F.; Torigoe, T.; Furuhata, T.; Idenoue, S.; Kurotaki, T.; Yamamoto, M.; Yagihashi, A.; Ohmura, T.; Yamaguchi, K.; Katsuramaki, T.; Yasoshima, T.; Sasaki, K.; Mizushima, Y.; Minamida, H.; Kimura, H.; Akiyama, M.; Hirohashi, Y.; Asanuma, H.; Tamura, Y.; Shimozawa, K.; Sato, N.; Hirata, K. Phase I Clinical Study of Anti-Apoptosis Protein, Survivin-Derived Peptide Vaccine Therapy for Patients With Advanced or Recurrent Colorectal Cancer. J. Transl. Med. 2004, 2, 19.
10. Tsuruma, T.; Iwayama, Y.; Ohmura, T.; Katsuramaki, T.; Hata, F.; Furuhata, T.; Yamaguchi, K.; Kimura, Y.; Torigoe, T.; Toyota, N.; Yagihashi, A.; Hirohashi, Y.; Asanuma, H.; Shimozawa, K.; Okazaki, M.; Mizushima, Y.; Nomura, N.; Sato, N.; Hirata, K. Clinical and Immunological Evaluation of Anti-Apoptosis Protein, Survivin-Derived Peptide Vaccine In Phase I Clinical Study for Patients With Advanced or Recurrent Breast Cancer. J. Transl. Med. 2008, 6, 24.
11. Mytilineos, J.; Lempert, M.; Scherer, S.; Schwarz, V.; Opelz, G. Comparison of Serological and DNA PCR-SSP Typing Results for HLA-A and HLA-B In 421 Black Individuals: A Collaborative Transplant Study Report. Hum. Immunol. 1998, 59, 512-517. (Pubitemid 28354971)
12. Gourley, I. S.; Kearns, J.; McKeen, M.; Birkos, S.; Brown, M.; Kamoun, M. HLA Class I Typing of Volunteers for a Bone Marrow Registry: QC Analysis by DNA-Based Methodology Identifies Serological Typing Discrepancies in The Assignment of HLA-A and B Antigens. Tissue Antigens. 2002, 59, 211-215. (Pubitemid 34666564)
13. Foung, S. K.; Taidi, B.; Ness, D.; Grumet, F. C. A Monoclonal Antibody Against HLA-A11 and A24. Hum. Immunol. 1986, 15, 316-319. (Pubitemid 16107739)
14. Ikeda, H.; Lethe, B.; Lehmann, F.; van Baren, N.; Baurain, J. F.; de Smet, C.; Chambost, H.; Vitale, M.; Moretta, A.; Boon, T.; Coulie, P. G. Characterization of An Antigen That is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing An NK Inhibitory Receptor. Immunity 1997, 6, 199-208. (Pubitemid 27145564)
15. Hirohashi, Y.; Torigoe, T.; Inoda, S.; Kobayasi, J.; Nakatsugawa, M.; Mori, T.; Hara, I.; Sato, N. The Functioning Antigens: Beyond Just as The Immunological Targets. Cancer Sci. 2009, 100, 798-806.
16. Olerup, O.; Zetterquist, H. HLA-DR Typing by PCR Amplification With Sequence-Specific Primers (PCR-SSP) in 2 hours: An Alternative To Serological DR Typing in Clinical Practice Including Donor-Recipient Matching in Cadaveric Transplantation. Tissue Antigens 1992, 39, 225-235.
17. Zetterquist, H.; Olerup, O. Identification of the HLA-DRB1*04, -DRB1*07, and -DRB1*09 Alleles by PCR Amplification With Sequence-Specific Primers (PCR-SSP) in 2 hours. Hum. Immunol. 1992, 34, 64-74.
18. Olerup, O.; Zetterquist, H. HLA-DRB1-01 Subtyping by Allele-Specific PCR Amplification: A Sensitive, Specific and Rapid Technique. Tissue Antigens 1991, 37, 197-204.
19. Gatz, S. A.; Pohla, H.; Schendel, D. J. A PCR-SSP method to Specifically Select HLA-A-0201 Individuals for Immunotherapeutic Studies. Tissue Antigens 2000, 55, 532-547.
20. Ishikawa, Y.; Tokunaga, K.; Tanaka, H.; Nishimura, M.; Muraoka, M.; Fujii, Y.; Akaza, T.; Tadokoro, K.; Juji, T. HLA-A Null Allele With a Stop Codon, HLA-A-0215N, Identified in a Homozygous State in a Healthy Adult. Immunogenetics 1996, 43, 1-5.
21. Laforet, M.; Froelich, N.; Parissiadis, A.; Bausinger, H.; Pfeiffer, B.; Tongio, M. M. An Intronic Mutation Responsible for a Low Level of Expression of An HLA-A-24 Allele. Tissue Antigens 1997, 50, 340-346. (Pubitemid 27405874)